1.44p-0.16 (-10.00%)22 Jul 2025, 16:40
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Cizzle Biotechnology Holdings PLC Fundamentals

Company NameCizzle Biotechnology Holdings PLCLast Updated2025-07-22
IndustryBiotechnologySectorHealthcare
Shares in Issue396.392 mMarket Cap£5.71 m
PE Ratio1.68Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.01EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0Debt Equity Ratio0
Asset Equity Ratio6.0000Cash Equity Ratio4.7195
Quick Ratio1.0098Current Ratio1.20
Price To Book Value77.5194ROCE0

Cizzle Biotechnology Holdings PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Cizzle Biotechnology Holdings PLC Company Financials

Assets202420232022
Tangible Assets000
Intangible Assets00£2.08 m
Investments000
Total Fixed Assets00£2.08 m
Stocks£2,000.0000
Debtors£27,000.00£27,000.00£132,000.00
Cash & Equivalents£387,000.00£1.56 m£478,000.00
Other Assets000
Total Assets£492,000.00£1.69 m£2.79 m
Liabilities202420232022
Creditors within 1 year£410,000.00£186,000.00£145,000.00
Creditors after 1 year000
Other Liabilities000
Total Liabilities£410,000.00£186,000.00£145,000.00
Net assets£82,000.00£1.51 m£2.64 m
Equity202420232022
Called up share capital£40,000.00£37,000.00£35,000.00
Share Premium£35.91 m£35.34 m£34.92 m
Profit / Loss-£2.19 m-£1.76 m-£963,000.00
Other Equity£82,000.00£1.51 m£2.64 m
Preference & Minorities000
Total Capital Employed£82,000.00£1.51 m£2.64 m
Ratios202420232022
Debt Ratio000
Debt-to-Equity000
Assets / Equity6.00006.00006.0000
Cash / Equity4.71954.71954.7195
EPS£-0.00£-0.00£-0.00
Cash Flow202420232022
Cash from operating activities-£358,000.00-£639,000.00-£872,000.00
Cashflow before financing£221,000.00-£334,000.00-£277,000.00
Increase in Cash£221,000.00-£334,000.00-£397,000.00
Income202420232022
Turnover000
Cost of sales000
Gross Profit000
Operating Profit-£2.19 m-£1.76 m-£963,000.00
Pre-Tax profit-£2.19 m-£1.76 m-£963,000.00

Cizzle Biotechnology Holdings PLC Company Background

SectorHealthcare
ActivitiesCizzle Biotechnology Holdings PLC is a cancer diagnostics company. It is engaged in development of test for the early detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker.
Latest Interim Date30 Sep 2024
Latest Fiscal Year End Daten/a

Cizzle Biotechnology Holdings PLC Directors

AppointedNamePosition
2011-08-09Mr. John Corelli James ThynneNon-Executive Director
2011-08-09Mr. Gareth JonesExecutive Director,Chief Technology Officer
2019-04-30Mr. Jonathan David Freeman Non-Executive Director,Chairman
2011-08-09Mr. Simon John Gibson OBENon-Executive Director
2016-05-31Dr. Andrew William Nelson OBENon-Executive Director
2011-08-09Mr. Owen Griffith Ronald JonesNon-Executive Director
2011-08-09Mr. Giles Alexander DaviesExecutive Director,Chief Financial Officer and Co Secretary
2012-06-27Mr. Ceri JonesExecutive Director,Chief Financial Officer and Company Sec
2025-04-30Dr. Allan John SymsExecutive Director,Chairman
2011-08-09Mr. Shaun Piers OxenhamExecutive Director,Chairman
2019-07-04Dr. James Stuart MckenzieExecutive Director,Chief Executive Officer
2019-07-04Dr. Majid ZoorobExecutive Director,Chief Technical Officer
2015-11-20Mr. Russell Anthony BanksExecutive Director,Chief Financial Officer
2016-06-23Mr. Philip Antony MarshallNon-Executive Director
2025-04-30Mr. John Michael TreacyNon-Executive Director
2025-04-30Mr. Dawn Alison CoverleyExecutive Director,Chief Scientific Officer
2025-04-30Mr. Nigel Ronald LeeExecutive Director,Finance Director
2025-03-25Mr. Edwin Matthew BowerNon-Executive Director

Cizzle Biotechnology Holdings PLC Contact Details

Company NameCizzle Biotechnology Holdings PLC
AddressHeslington Hall, Heslington, York, YO10 5DD
Telephone+44 207264444
Websitehttps://www.cizzlebiotechnology.com

Cizzle Biotechnology Holdings PLC Advisors

StockbrokerPeterhouse Corporate Finance Ltd
Phone+44 2074690930
Fax+44 2072209798
Nominated AdviserNorthland Capital Partners
Phone+44 2038616625
Fax+44 2076005975
StockbrokerNorthland Capital Partners
Phone+44 2038616625
Fax+44 2076005975
SolicitorGreenaway Scott LLP
Phone029 2009 5500
RegistrarLink Asset Services
Phone+44 8716640300
Fax+44 2086392342
Financial PR AdviserInstinctif Partners
Phone+44 2074572020
BankBarclays Bank PLC